Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Taylor Andrew Lawrence, Chief Financial Officer. Insider active across 2 companies, notably Motus GI Holdings, Inc.. Aggregated, 16 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €9k. History available since 10 February 2022. The latest transaction was disclosed on 26 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Taylor Andrew Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,000 shares@ €0.4491100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001213900-21-061014:0
Canonical exit: 17 Feb 2022 (T+90)
16 of 16 declarations
About Taylor Andrew Lawrence
Taylor Andrew Lawrence is Chief Financial Officer, with disclosed roles at Orchestra BioMed Holdings, Inc. and Motus GI Holdings, Inc. He has 15 filings in total, and across the 15 sampled filings the buy amount is EUR 9056 and the sell amount is EUR 0, covering the period from 2021-11-22 to 2026-02-13. The modal transaction nature is Attribution.